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The Burkholderia cenocepacia epidemic ET12 lineage belongs to the genomovar
IIIA including the reference strain J2315, a highly transmissible epidemic
B. cenocepacia lineage. Members of this lineage are able to cause lung infections in
immunocompromised and cystic fibrosis patients. In this study, we describe the genome
of F01, an environmental B. cenocepacia strain isolated from soil in Burkina Faso that is,
to our knowledge, the most closely related strain to this epidemic lineage. A comparative
genomic analysis was performed on this new isolate, in association with five clinical and
one environmental B. cenocepacia strains whose genomes were previously sequenced.
Antibiotic resistances, virulence phenotype, and genomic contents were compared and
discussed with an emphasis on virulent and antibiotic determinants. Surprisingly, no
significant differences in antibiotic resistance and virulence were found between clinical
and environmental strains, while the most important genomic differences were related to
the number of prophages identified in their genomes. The ET12 lineage strains showed
a noticeable greater number of prophages (partial or full-length), especially compared
to the phylogenetically related environmental F01 strain (i.e., 5–6 and 3 prophages,
respectively). Data obtained suggest possible involvements of prophages in the clinical
success of opportunistic pathogens.
Keywords: Burkholderia cenocepacia, Burkina Faso, virulence factors, RND pumps, prophages, antibiotic
resistance
INTRODUCTION
The Burkholderia cepacia complex (Bcc) is a group of opportunistic pathogens that cause lung
infections in immunocompromised and cystic fibrosis (CF) patients. The Bcc (originally described
as Pseudomonas cepacia) comprises 20 taxonomically related species frequently isolated in water
or soil, including plant-associated environments (Ramette et al., 2005; De Smet et al., 2015).
Burkholderia multivorans and B. cenocepacia (formerly Genomovar II and III, respectively) are
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the most clinically frequent members of Bcc, representing from
50% up to 80% of the infections caused by this complex
(Mahenthiralingam et al., 2002; Holden et al., 2009; Peeters et al.,
2017). Unlike other opportunistic pathogens isolated from CF
patients (e.g., Haemophilus influenzae or P. aeruginosa), members
of the Bcc could lead to the “cepacia syndrome.” This syndrome is
characterized by a rapid clinical deterioration due to necrotizing
pneumonia or sepsis, resulting in early death (Isles et al., 1984;
Gibson et al., 2003). Moreover, several Bcc species have been
shown to be transmissible among CF patients and are able to
cause epidemic outbreaks (Biddick et al., 2003).
Given that isolate can result of variable virulence traits
depending on the infected patient (Isles et al., 1984; Govan
et al., 1993), the determinants of the cepacia syndrome are
complex. Indeed, many virulence factors have been highlighted
in B. cenocepacia (Drevinek and Mahenthiralingam, 2010; Leitao
et al., 2010; Bazzini et al., 2011a; Schwager et al., 2013). Briefly,
expression of the cable pilus (cblA), as well as a 22 kDa adhesion,
are required for the initial adhesion of the bacteria to the surface
of lung epithelial cells (McClean and Callaghan, 2009). Moreover,
a functional flagella and lipase are necessary for cell invasion
(Tomich et al., 2002; Mullen et al., 2007), and several other
virulence factors enhance the B. cenocepacia pathogenicity, like
LPS, metalloprotease, siderophores or secretion systems (Leitao
et al., 2010; McKeon et al., 2010). Cell-cell communication by
quorum sensing (QS), have been described in B. cenocepacia to
coordinate expression of these different virulence factors, most of
them being necessary for the virulence and also for the normal
physiology of B. cenocepacia (Leitao et al., 2010).
Clinical strains of Bcc exhibit high levels of antibiotic
resistance that participates to the mortality of the CF patients
(Foweraker, 2009). Multiple mechanisms were described as
responsible for this drug resistance, including the production of
modifying or degrading enzymes, antibiotic target alterations,
cell permeability, and drug efflux. In addition, Bcc strains are
able to form biofilm on various biotic and abiotic surfaces,
increasing their drug tolerance (Coenye, 2010). Because high
level of resistance to most of antibiotics (β-lactams, polymyxins,
and aminoglycosides) is now commonly found in Bcc strains,
treatment of B. cenocepacia by triple antibiotic combination
has been proposed (Aaron et al., 2000). Among the antibiotic
resistance mechanisms of greatest concern, the RND (Resistance-
Nodulation-Cell Division) pumps are particularly problematic
because they catalyze the active efflux of many chemically
different molecules and, consequently, participate in the multi-
drug resistance (MDR) phenotype (Li et al., 2015). No fewer
than 15 RND efflux pumps have been described in B. cenocepacia
J2315, and their roles in antibiotic resistance was demonstrated
for at least 5 of them (Bazzini et al., 2011b; Buroni et al.,
2014).
DNA–DNA hybridization and phylogenetic analysis of the
recA gene revealed the presence of four distinct recA lineages
within B. cenocepacia, i.e., genomovar IIIA to IIID (Vandamme
et al., 2003). Even though no clear distinction has been established
between clinical and environmental Bcc strains on the basis of
phenotypic or genotypic criteria (Bevivino et al., 2002; Peeters
et al., 2017), B. cenocepacia strains isolated from CF patients
seem to be more invasive and more virulent than environmental
strains (Pirone et al., 2008; Bevivino et al., 2012). Moreover,
B. cenocepacia IIIA strains were rarely found outside of human
infections in comparison to other B. cenocepacia and the Bcc
(Baldwin et al., 2007). In particular, the B. cenocepacia epidemic
ET12 lineage, which belongs to the genomovar IIIA and includes
the reference strain J2315 (also known as LMG 16656T), is
a highly transmissible epidemic B. cenocepacia lineage that
emerged from the Canada and spread to Europe during the 1990s
(Holden et al., 2009). In this study, we describe the genome of
F01, a new environmental B. cenocepacia strain isolated from
soil in Burkina Faso. This environmental strain presents the
same recA sequence as J2315, and is, to our knowledge, the
most closely related environmental strain to the epidemic ET12
lineage. A comparative genomic analysis was performed on the
genome of this environmental strain, together with available
genomes of five clinical and one environmental B. cenocepacia
(i.e., J2315, BC7, K56-2, H111, MCO-3, and AU1054 strains).
Phylogenetic relationships between these seven B. cenocepacia
strains were investigated. In addition, antibiotic resistances,
virulence phenotype and genomic contents were compared and
discussed.
MATERIALS AND METHODS
Bacterial Strains and Sampling Sites
The B. cenocepacia strain F01 was isolated form an agricultural
soil in the periphery of Ouagadougou in Burkina Faso (sub-
sahelian climate). The soil was sampled in a field planted with
sorghum in June 2008, 6 months after the crop harvest (Youenou
et al., 2016). Characterization of the strain F01 according to
the Bcc was performed as described in Mahenthiralingam et al.
(2000) by amplification of 1043 bp of the recA gene with BCR1
and BCR2 primers.
Six previously sequenced B. cenocepacia strains from clinical
and environmental origins were included in the study (Table 1).
The genomes were obtained from NCBI website1 and the strains
were kindly provided by Dr. Goldberg and Dr. Varga. Briefly,
the B. cenocepacia stains J2315 (Holden et al., 2009), BC7 and
K56-2 (Varga et al., 2013) are members of the highly transmissible
genomovar IIIA (ET12 lineage) and were all isolated from CF
patients. The B. cenocepacia strain H111 is also a member of
the genomovar IIIA isolated from CF patient, but this strain
is not included in the ET12 lineage (Carlier et al., 2014). The
B. cenocepacia strain AU1054 is a member of the genomovar IIIB
isolated from a CF patient (Chen et al., 2001). The B. cenocepacia
strain MCO-3 is a member of the genomovar IIIB isolated from
the rhizosphere of maize (A. Baldwin, unpublished).
Genome Sequencing and Assembly
The draft genome of the strain F01 was performed by the
DTAMB/Biofidal structure at the University of Lyon (France)
using a Roche 454 GS Junior sequencer (454 Life Sciences,
Branford, CT, United States) combined with an Illumina MiSeq
1http://www.ncbi.nlm.nih.gov/
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approach (Illumina, San Diego, CA, United States). The 454 run
led to 143,478 reads with an average read length of 597 bp. The
Illumina MiSeq PE 2× 300 led to 4,946,130 paired-end reads with
a mean length of about 195 bp after trimming, a final coverage
of× 73 being generated (Table 1). Reads were de novo assembled
using the SPAdes version 3.10.1 (Bankevich et al., 2012). The
contigs were reordered according to the genome sequence of the
reference strain J2315 using the Mauve Contig Mover (Rissman
et al., 2009) of the MAUVE software (Darling et al., 2004). The
contigs that could not be replaced according to the J2315 genome
sequence were placed at the end of the alignment.
The nucleotide sequences of the strain F01 was deposited into
the European Nucleotide Archive2 with the accession number
ERS2025400 (the study accession is PRJEB23651).
Genome Annotation and Comparative
Genomics
Coding sequences (CDSs) predictions, as well as automatic
and manual sequence annotations, were performed using the
MicroScope platform pipeline at Genoscope (Vallenet et al.,
2013). CDSs were predicted using AMIGene software (Bocs et al.,
2003). Automatic functional annotation of the predicted CDSs
was performed using the tools integrated in the MicroScope
platform (Vallenet et al., 2009). Gene predicted to be involved
in functions of interest were manually investigated by using
the “genome browser” tool of the platform. Genomic islands
and regions of genomic plasticity (RGPs) of each genome
were identified using the “RGP finder” tool included in the
MicroScope platform by searching for synteny breaks and
HGT (horizontally transferred genes) features (Vernikos and
Parkhill, 2006; Waack et al., 2006). Antibiotic resistance genes
(ARGs), including intrinsic, mutation-driven and acquired
resistance, were searched using the CARD database version
1.1.2 (Comprehensive Antibiotic Resistance Database; McArthur
et al., 2013) included in the MicroScope platform. Prophage
sequences were identified using the PHASTER tool (Arndt et al.,
2016) and manually confirmed by eliminating false positive
“incomplete prophages” (e.g., transposons). In addition, clustered
regularly interspaced short palindromic repeats (CRISPRs) were
investigated using the CRISPR Finder tool (Grissa et al., 2007).
Phylogenetic Analysis
The evolutionary relationships among the seven studied
B. cenocepacia strains were determined from a concatenated
alignment of the orthologous protein sequences of the core
genome of these seven strains. Orthologous proteins were
identified from bidirectional best-hit BLASTP searches of each
strain proteome against J2315’s proteome with an e-value
parameter threshold of 10e−5. Customized computer scripts
were then used to extract the best reciprocal hits from all the
strains and to align these protein sequences with Clustal omega
(Sievers et al., 2011). The alignments were then filtered using
Gblocks version 0.91 b (Talavera and Castresana, 2007) with
default options and concatenated. A final alignment of 4,555
concatenated proteins (1,514,675 amino acids) was used for the
2http://www.ebi.ac.uk/ena
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phylogenetic analyses. A phylogenetic tree was reconstructed
with the maximum-likelihood method by implementation
in RAxML V7.9.5 (Stamatakis, 2006) with 1,000 bootstraps
replicates. The phylogenetic tree root was confirmed to be
positioned between the two genomovar IIIA and IIIB by
reiterating the same protocol with 29 additional Burkholderia
spp. genomes (data not shown).
Multilocus sequence typing (MLST) of the seven studied
strains was performed using seven standard housekeeping genes
(atpD, gltB, gyrB, lepA, phaC, trpB, and recA) according to the
protocol and primers specified in a public database of MLST
sequence data3 (Spilker et al., 2009). The sequences were obtained
from the sequenced genomes.
Nitrate Respiration Test
Nitrate anaerobic respiration was evaluated using the API
20NE kit (bioMérieux, Marcy-l’Étoile, France), according to the
manufacturer’s recommendations.
Antibiotic Resistance Test
Antibiotic resistances of the strain F01, as well as the
six previously sequenced B. cenocepacia strains included in
our study were determined by the agar diffusion method
using a set of 16 antibiotic disks (Bio-Rad, Marnes-la-
Coquett, France). The antibiotics tested corresponded essentially
to the officially recommended drugs for use in human
medicine against infections caused by non-fermenting gram
negative bacilli, in particularly against B. cepacia: Ticarcillin
(TIC, 75 µg), Ticarcillin + clavulanic acid (TCC, 75 + 10 µg),
Piperacillin + tazobactam (PPT, 75 + 10 µg), Ceftazidime
(CAZ, 30 µg), Cefepime (FEP, 30 µg), Cefpirome (CPO, 30 µg),
Chloramphenicol (CHL, 30 µg), Imipenem (IPM, 10 µg),
Meropenem (MEM, 10 µg), Ofloxacin (OFX, 5 µg), Levofloxacin
(LVX, 5 µg), Ciprofloxacin (CIP, 5 µg), Pefloxacin (PEF, 5 µg),
Minocycline (MNO, 30µg), Colistin (CST, 50µg), Trimethoprim
+ sulfamethoxazole (SXT, 23.75 + 1.25 µg). After 24 h at
35◦C, the strains were classified as susceptible, intermediate or
resistant according to French national guidelines4. P. aeruginosa
CIP 76110 (ATCC 27853) was used as control.
Virulence Assays
Virulence was determined using the Dictyostelium discoïdeum
social amoeba, as previously described (Froquet et al., 2009).
Strains of P. aeruginosa PT5 and Klebsiella pneumoniae KpGe
were used as negative and positive control for each assay. The
axenic D. discoïdeum strain AX2 (kindly provided by Anne
Vianney, CIRI, University Lyon1) was used for virulence assays.
Overnight bacterial culture was diluted in Luria–Bertani (LB)
medium to reach an OD600 nm of 1.5. Then, 1 mL of each bacterial
suspension was plated on SM Agar (Formedium, Hunstanton,
United Kingdom) medium. Plates were dried for 1 h to obtain
a dry bacterial layer. Meanwhile, cells of D. discoïdeum were
washed two times in PAS buffer (Page’s Amoeba Saline buffer;
2.5 mM KH2PO4, 4 mM MgSO4, 0.5 mM CaCl2, 2.5 mM,
3http://pubmlst.org/bcc/
4http://www.sfm-microbiologie.org/
NA2HPO4, 0.05 mM (NH4)2FeII(SO4)2) by centrifugation at
1000 × g for 10 min. Suspension of amoebae was then adjusted
to 2× 106 cells per ml. This suspension was diluted in series until
a final density of about 7800 cells per ml. Five microliters of each
dilution were spotted on bacterial lawns. Plates were incubated at
22.5◦C during 5 days. After incubation, appearance of phagocytic
plaques was evaluated according three categories (Adamek et al.,
2011): (i) non-virulent (less than 400 amoebae for lysis plaque
formation), (ii) low-virulent (400–2500 amoebae for lysis plaque
formation) and (iii) virulent (more than 2500 amoebae). Data
shown are the means of two independent experiments, each
performed in triplicate
RESULTS
Core Genome Phylogeny and Multilocus
Sequence Typing (MLST)
Sequencing of the recA gene of the strain F01 showed the same
sequence as the B. cenocepacia stains J2315. Using reciprocal
BLASTP, protein-coding genes having a 1:1 orthologous
relationship to each other were identified across the seven
studied B. cenocepacia. A total of 4,555 CDSs were identified
which could be considered as the core genome for those strains.
A final alignment of 1,514,675 amino acids was used for the
phylogenetic tree reconstruction by maximum-likelihood
method (Figure 1). Interestingly this phylogenetic tree is
almost fully resolved, with bootstrap values ≥ 99%. Both strains
belonging to genomovar IIIB (strains MC0-3 and AU 1054), as
defined from the recA sequence, were clearly separated from
strains belonging to genomovar IIIA. Moreover, the three strains
belonging to the epidemic ET12 lineage (strains J2315, BC7
and K56-2), as defined by multilocus enzyme electrophoresis,
grouped together. Interestingly, our new environmental F01
strain was closer to the ET12 lineage than the clinical strain
H111.
To further investigate these evolutionary relationships, a
MLST analysis was performed (Figure 1). In this study, all
genomovar IIIA strains belong to the same clonal complex
(i.e., ≥4 alleles out of 7 are identical), while the two strains of
genomovar IIIB belong to two different clonal complexes. In
addition, all strains showed a different sequence type (ST), except
the strains J2315 and BC7, which belongs to the ST-28. The ST
of the F01 strain is new (ST-1363) because of a new allele for the
atpD gene (atpD-437).
General Features of the F01 Genome and
Comparative Genomics
The draft genome of F01 consisted of 8,041,553 bp organized
in 91 contigs of size greater than 200 bp (Table 1). Therefore,
F01 has a genome size close to the other B. cenocepacia strains,
i.e., between 7,991,017 bp (for BC7) and 8,055,782 (for J2315).
Moreover, the average GC content of the F01 genome was 67.2%,
that is consistent with the average GC content of the other
B. cenocepacia (66.9% ± 0.3; Table 1). The sequencing methods
used in our study (Roche 454 and Illumina MiSeq) did not allow
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FIGURE 1 | Phylogenetic tree from maximum-likelihood analysis of the
core-genome alignments of seven Burkholderia cenocepacia strains. In total,
4,555 orthologous proteins were concatenated in an alignment of 1,514,675
amino acids. Bootstraps are indicated in each node. ST, Sequence Type
(unique combination of 7 alleles; see Materials and Methods). Two strains
belong to the same clonal complex if they share at least four identical alleles.
performing the complete genome assembly, because reads were
too short to overcome some repeat regions. Thus, the number of
chromosomes and presence of plasmids could not be determined
in F01, as well as in the other draft genomes available (Table 1).
Nevertheless, the “Genome Browser interface” available in the
Microscope platform5) allowed to visualize a global synteny in
F01 for the three chromosomes as well as for the plasmid of
J2315 (data not shown). This synteny was also conserved in
the other B. cenocepacia strains studied except for the plasmid
that was not detected in the strains H111, MC0-3 and AU
1054.
In total, 8,185 predicted protein-CDSs were identified
in the F01 genome that is noticeably higher than the
average number of CDSs in the other B. cenocepacia strains
(7495 bp ± 370). Another difference was the number of
tRNAs, which was lower in F01 and H111, compared to the
other strains (59 vs 67–74), although this last observation is
questionable because of the sequencing technique used which
may underestimate the number of repeated genes. Concerning
the general genomic features, the most difference was the
number of partial or full-length prophages detected (Table 1).
Indeed, the ET12 lineage strains showed a higher number
of (partial or full-length) prophages, with 5–6 prophages
detected against 1–4 for the other B. cenocepacia strains. More
generally, the number of full-length prophages (i.e., potentially
functional prophages) seemed associated with the phylogenetic
relationships, with 2–4 full-length prophages in genomovar IIIA
and only one in genomovar IIIB. However, in genomovar IIIA,
the environmental F01 strain presented the lowest number
5https://www.genoscope.cns.fr/agc/microscope
of full-length prophages (Table 1). In addition, no CRISPR
system were detected in the seven B. cenocepacia genomes
studied.
Comparative genomics by reciprocal Blast was then
performed. Beside the core genome of 4,555 CDS that were
used for phylogenetic analysis (Figure 1), particular attention
was given to variable genes. First of all, we observed that
the number of strain-specific genes varied between strains
(Table 1). The low number of strain-specific genes observed
in the ET12 lineage (from 139 to 391 genes) was probably
due to the close phylogenetic relationships between the three
strains J2315, BC7 and K56-2 (Figure 1). However, the highest
number of strain-specific genes in the two environmental
strains F01 and MC0-3 (1463 and 1176 genes, respectively)
could not be phylogenetically explained, when compared
to the clinical strains H111 and AU 1054 (599 and 760
genes, respectively), and could be associated with their
environmental life style. Annotation of strain-specific genes
mainly corresponded to proteins of unknown function
(65.0% ± 13.3, compared to 16.7% for the core genome).
Despite this lack of annotation, and beside the genes associated
with phages, transposition or expression regulation, we
focused on two gene categories. On the one hand, several
genes specific to F01 were described as involved in xenobiotic
degradation, in particular monoxygenases, dioxygenases,
cyclases or cytochromes encoding genes, potentially responsible
for the degradation of RDX (i.e., Hexahydro-1,3,5-trinitro-1,3,5-
triazine) and chlorophenolic compounds (e.g., F01_v2_460557,
F01_v2_460615 to F01_v2_460617). On the other hand,
analysis of putative metabolic functions revealed more putative
genes involved in nitrate respiration, compared to the other
B. cenocepacia strains. However, although nitrate respiration was
phenotypically confirmed by API gallery in F01, this feature was
also found among some of our studied B. cenocepacia strains
(e.g., J2315 and MC0-3).
Variable genes among our seven strains studied were also
analyzed by two additional approaches. On one hand, a genomic
comparison was performed between the two environmental
strains (F01 and MC0-3) and the five other clinical strains. On
the other hand, a comparison limited to the genomovar IIIA
was performed between F01, H111 and the ET12 lineage strains
(J2315, BC7 and K56-2). (i) The first comparison showed only
eight genes present in all the clinical strains of B. cenocepacia
and absent in the two environmental strains. Among these eight
genes, the only functionally characterized gene (BCAM2106 in
J2315) encodes a non-heme chloroperoxidase, associated with
response to oxidative stress. Conversely, 23 genes specific to
environmental strains and absent in clinical strains were also
highlighted. These genes corresponded to a prophage partially
conserved between the two environmental strains and absent in
clinical strains (Table 2). (ii) The second comparison revealed
745 genes specific to the ET12 lineage strains and absent
in the other genomovar IIIA strains. Most of these genes
(62.1%) encoded putative proteins of unknown function, while
best described genes corresponded to transposons, expression
regulation genes and the four prophages specific to the ET12
lineage (Table 2).
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TABLE 3 | Antibiotic resistances of seven studied B. cenocepacia strains.
Drug Class J2315 BC7 K56-2 F01 H111 MC0-3 AU1054
Piperacillin + tazobactam Penicillin Sa S I S S R S
Ticarcillin Penicillin R R R R R R R
Ticarcillin + clavulanic acid Penicillin R R R R R R R
Imipenem Carbapenem R R R R R S R
Meropenem Carbapenem S I I S I S S
Cefepime Cephalosporin S S R S R R R
Cefpirome Cephalosporin R R R R R R R
Ceftazidime Cephalosporin S S S S S S R
Chloramphenicol Phenicol S S S S S S R
Minocycline Tetracylcine S S S S S S S
Colistin Polymyxin R R R R R R R
Tripmethoprim + sulfamethoxazole Sulfamide-Trimethoprim I S S S S S R
Ciprofloxacin Fluoroquinolone R S R R R R R
Levofloxacin Fluoroquinolone I S R I S I R
Ofloxacin Fluoroquinolone R R R R R R R
Pefloxacin Fluoroquinolone R S I R I R R
a Interpretations were made according to the recommendations of the antibiogram committee of the French society of microbiology. R, resistant; I, intermediate;
S, susceptible.
Resistances to Antibiotics
Resistance phenotypes across 16 antibiotics and combinations
were investigated using the disk diffusion method (Table 3).
Five studied B. cenocepacia strains (J2315, K56-2, F01, H111
and MC0-3) showed a similar number of antibiotic resistances,
with resistance to about half of the tested antibiotics. Indeed, all
these strains were resistant to ticarcillin (alone or in combination
with clavulanic acid), cefpirome, colistin, and ofloxacin. These
same strains were susceptible to ceftazidime (a third generation
cephalosporin), chloramphenicol, and minocycline (Table 3).
Interestingly, no significant differences were found between
the antibiotic resistance profiles of clinical (J2315, K56-2, and
H111) and environmental (F01 and MC0-3) strains. The BC7
strain was the most susceptible of the strains tested, particularly
against fluoroquinolones with susceptibility to ciprofloxacin and
pefloxacin. The AU1054 strain was the most resistant of the
B. cenocepacia strains studied, with a resistance to 13 out of the
16 antibiotics tested. Notably, AU1054 is resistant to ceftazidime,
chloramphenicol, and the combination of trimethoprim and
sulfamethoxazole (Table 3).
In addition to the phenotypic assays, the comprehensive
antibiotic resistance database (CARD), including resistance
genes and mutations conferring antibiotic resistance,
was used to predict the resistome of the strains studied
(Supplementary Table S1). The resolution of the CARD database
ontology is often at the antibiotic class level, which does not allow
a direct comparison with resistance phenotypes. In addition, it
is well known that ARGs must be expressed to provide effective
resistance. Indeed, our genomic resistome analysis suggested
potential resistance to all classes of antibiotics, even for strains
revealing a susceptible phenotype (Supplementary Table S1).
Differences observed between resistomes concern only genes
encoding efflux pumps, notably the resistance nodulation
cell-division (RND) pumps, as well as a specific allele of the
katA gene involved in the resistance to isoniazid. Indeed, while
all genomes contain both katA and katB genes, potentially
conferring resistance to isoniazid, only katB was found in the F01
genome (Supplementary Table S1).
Because many RND efflux pumps involved in antibiotic
resistance have already been described in B. cenocepacia, the
genes encoding these pumps were exhaustively researched
among the strains studied (Supplementary Table S3). 16
CDSs annotated as probably encoding 15 RND efflux pumps
(HAE-1 and HME families) were found in J2315 (including a
heterotrimeric RND pump). A role in antibiotic resistance was
demonstrated for at least five of them (Bazzini et al., 2011b).
In all the studied B. cenocepacia, only 13 of these 16 CDSs
were highlighted, including the five efflux pumps involved in
antibiotic resistance (Supplementary Table S3). The RND-12
pump, involved in copper efflux (HME family), is absent in H111,
while the RND-15 pump, whose function is unknown, is absent
in the two strains of genomovar IIIB (MC0-3 and AU1054),
as confirmed by synteny study (Supplementary Table S3).
Interestingly, genes potentially encoding the same RND pumps
(HAE-1 and HME families) were found in the three strains of
the ET12 lineage as well as in the environmental F01 strain
(Supplementary Table S3). In H111, additional genes encoding
for two other HAE-1 efflux pumps, and potentially involved in
antibiotic resistance, were found. This strain therefore has genes
encoding 16 potential RND pumps. In the two genomovar IIIB
strains (MC0-3 and AU1054), additional genes encoding for three
other efflux pumps were found, including a HAE-1 efflux pump
homologous (orthologous) to one of the additional H111 pumps.
Moreover, one of the genes encoding efflux pump is a pseudogene
(Bcen_3622, RND-9). MC0-3 therefore has genes encoding 17
potential RND pumps.
Frontiers in Microbiology | www.frontiersin.org 7 March 2018 | Volume 9 | Article 383
fmicb-09-00383 March 2, 2018 Time: 15:48 # 8
Bodilis et al. Environmental Burkholderia Related to Epidemic Lineage
Virulence
The virulence phenotype of the seven strains of interest was
determined by using the D. discoïdeum model (Froquet et al.,
2009). This assay measures the lowest number of amoeba cells
required for effective bacterial predation. The higher the number
of amoebae required for bacterial killing, the higher is the ability
of bacteria to resist predation. Our results revealed that all
B. cenocepacia strains can be considered as virulent, compared to
the P. aeruginosa PT5 positive control (Figure 2). Indeed, these
strains were able to resist predation of the maximum amount of
amoebae tested, excepted for AU1054 which displayed a slightly
less virulent phenotype compared to the other B. cenocepacia
strains. This assay did not seem to display any significant
difference of virulence between clinical and environmental
strains (Figure 2).
Additionally, our analysis of the literature currently available
on B. cenocepacia virulence genes (Aubert et al., 2008; Drevinek
and Mahenthiralingam, 2010) highlighted that almost all
virulence genes identified in members of the epidemiologic
ET12 lineage are also present in the environmental strain
F01, including genes encoding the cable pilus, previously
described as ET12 lineage-specific (McClean and Callaghan,
2009) (Supplementary Table S2). Only the genes katA and
wbcE (annotated as glycosyl transferase, and involved in
lipopolysaccharide synthesis) were absent in the F01 genome.
Finally, genes encoding proteins involved in QS, synthesis of
cable pilus, iron acquisition or rhamnolipid synthesis were absent
in the genomovar IIIB strains, as well as in the H111 strain
(Supplementary Table S2).
DISCUSSION
B. cenocepacia, especially strains from the ET12 lineage, are
among the most prevalent Bcc members that colonize CF patients
(Isles et al., 1984; Speert et al., 2002; Mahenthiralingam et al.,
FIGURE 2 | Virulence of B. cenocepacia strains determined using the social
amoeba Dictyostelium discoïdeum. Strains of Pseudomonas aeruginosa PT5
and Klebsiella pneumoniae KpGe were used as positive and negative control,
respectively. The axenic D. discoïdeum strain AX2 was used for virulence
assays. Dilutions of amoebae were spotted on bacterial lawn plates and
incubated during 5 days (n = 6).
2005; Drevinek and Mahenthiralingam, 2010). However, despite
that many virulence factors were described, the epidemiological
success of some lineages is still misunderstood (Holden et al.,
2009; McClean and Callaghan, 2009; Bazzini et al., 2011a; Gonyar
et al., 2015). The B. cenocepacia species is characterized by a
large variety of ecological niches, from patient-associated to
environmental niches. Although some studies have shown that
clinical strains of B. cenocepacia have a higher virulence than
environmental strains (Pirone et al., 2008; Bevivino et al., 2012),
the distinction between clinical and environmental strains based
on phenotypic or genotypic criteria remains difficult (Bevivino
et al., 2002; Peeters et al., 2017). Indeed, to our knowledge, strains
belonging to the ET12 lineage had not yet been isolated from
a non-clinical environment (Baldwin et al., 2007). Thus, this
is the first time that an environmental strain phylogenetically
related to the ET12 lineage, is described. The environmental
F01 strain belongs to the same clonal complex and possess, to
date, the phylogenetically closest genome to ET12 genomes, by
comparison to other available B. cenocepacia genomes (Figure 1).
In this context, this study provides a new evolutionary aspect
to understanding the emergence of the ET12 lineage, and
more generally, the epidemic risk represented by opportunistic
pathogens.
The presence of genes involved in xenobiotic degradation
and nitrate respiration suggested that F01 is well adapted to
agricultural soil. Historically, F01 was isolated in 2008 from a soil
characterized by an absence of amendment for at least 10 years
(Youenou et al., 2016). A recent anthropogenic origin of F01
could therefore be excluded. Moreover, it is important to notice
that another strain with a similar recA sequence (also similar to
J2315 recA sequence) was isolated 3 years later from the same
site (data not shown). Although we cannot affirm that this isolate
is a direct descendant to F01, this strain displayed specific traits
in common with F01 (i.e., same virulence phenotype, ability to
metabolize nitrate, same pattern of antibiotic resistances) (data
not shown). Taken together, these two isolates show that strains
adapted to agricultural soils can be phylogenetically related to the
ET12 epidemic lineage.
This observation raises the question of the specific pathogenic
properties of strains involved in clinical infections, particularly
when these strains have been described as opportunistic
pathogens. So, among phylogenically related strains why some
displayed an efficient success in clinical situations and not the
others? Beyond the capacity for infection, are there specific
properties of opportunistic pathogenic strains that explain their
epidemiological success? In an attempt to answer these questions,
we conducted in this present work a comparative study between
ET12 strains and our new environmental strain of B. cenocepacia,
focusing on two parameters that characterize clinical strains:
antibiotic resistances and virulence.
Surprisingly, no significant differences in antibiotic resistance
were found between ET12 strains and F01, as well as
between clinical and environmental strains of genomovar IIIB
(Table 3). As previously observed, the numerous RND pumps
in B. cenocepacia are likely to represent the main genetic
determinants responsible for the MDR phenotype frequently
described in this bacterial species (Holden et al., 2009;
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Perrin et al., 2010; Bazzini et al., 2011b; Buroni et al., 2014).
Interestingly, although this cannot be correlated with the
phenotypes observed, some variation in the number of RND
efflux pump genes between the B. cenocepacia strains were
observed, while the other ARGs are almost all conserved in
this bacterial species (Supplementary Table S3). Although the
genes coding for RND pumps are generally found as conserved
in a given bacterial species, we already identified horizontal
gene transfers coding for such efflux pumps in environmental
strains of Stenotrophomonas maltophilia, potentially associated
with an MDR phenotype (Youenou et al., 2015; Bodilis et al.,
2016). Because, both organic (e.g., PAHs; Hearn et al., 2003)
and inorganic (e.g., metals; Nies, 1995) contaminants, as well
as root exudates (Eda et al., 2011), were previously described
as inducers and/or substrates of RND efflux pumps, a role of
these environmental factors in the selection and dissemination
of efflux-mediated resistances is probable (Martinez et al., 2009).
Without necessarily directly inducing an increase in antibiotic
resistance in these environmental opportunistic pathogenic
strains, such factors could at least promote future clinical
adaptability by selecting strains with multiple efflux pumps.
Indeed, the emergence of multidrug-resistant bacteria is often
linked to mutations that overexpress efflux pumps (Li et al., 2015).
As surprising as the results of antibiotic resistance phenotypes,
all strains of B. cenocepacia, including F01, were virulent,
according to our amoeba assay (Figure 2). In genomovar
IIIB, we observed a probable non-significant slight decrease
in virulence for the clinical strain (AU1054) compared to
the environmental strain (MC0-3). The phenotypic virulence
assay we used was validated by several studies on strains of
B. cenocepacia or other opportunistic pathogenic species (Aubert
et al., 2008; Froquet et al., 2009; Steinert, 2011). Moreover, the
conservation of the virulence phenotype that we observed for
all the B. cenocepacia tested is in agreement with the presence
in their genome of most of the genes encoding the virulence
factors already described in J2315 (Supplementary Table S2).
Additional tests on other environmental strains of Burkholderia
spp. showed virulence traits in all of the B. cenocepacia tested,
while other Burkholderia spp. (e. g., B. dolosa and B. multivorans)
were not virulent (data not shown). Although this should be
deeply investigated, the virulence phenotype of Burkholderia spp.
appears to be species-specific and not related to the clinical
origin of the strains. This observation is in connection with
other studies showing a significant number of opportunistic
pathogenic bacteria in the rhizosphere. This environment could
select bacterial virulence properties during interaction with plant
roots or during the intense microbial competition present in the
rhizosphere (Berg et al., 2005; Mendes et al., 2013). Recently, a
study has even shown that a rhizospheric B. cenocepacia strain
enhances its virulence during mice infection (Bragonzi et al.,
2017). Consequently, although several Bcc strains have developed
beneficial interactions with their plant hosts, the difficulties of
distinguishing between pathogenic and harmless strains prevents
the use of Bcc members as biocontrol agents (e.g., Vial et al.,
2011).
Beyond the virulence, we also considered the epidemiological
properties of ET12 strains, notably the genomic signatures
specific to these clinical strains. Thus, Cable A is one of
the few virulence factors previously described as specific to
ET12 strains (Graindorge et al., 2010). However, we also
identified the gene encoding this virulence factor in the genome
of the environmental strain F01 (Supplementary Table S2),
excluding an epidemiological signature associated with this
gene. Similarly, the plasmid initially described in J2315 is
found in all ET12 strains and in the environmental strain
F01. An analysis of the databases revealed that this plasmid
is also present in B. cenocepacia HI2424 (genomovar IIIB)
and other Burkholderia species (B. thailandensis, B. gladioli,
and B. glumae) (data not shown). Therefore, the occurrence
of this plasmid in Burkholderia spp. does not appear to be
related to particular species, environment, or virulence. Finally,
the occurrence of prophages in the genome of ET12 strains
appears to be the most interesting epidemiological signature
(Table 2).
The most important differences, especially in genomovar
IIIA, were therefore related to the number of prophages
identified in the genomes (Table 1). The ET12 lineage strains
displayed a noticeable greater number of (partial or full-
length) prophages, especially compared to the phylogenetically
related environmental F01 strain (i.e., 5–6 and 3 prophages,
respectively). However, it is difficult to determine whether these
prophages are directly involved into the ecological adaptation
or whether they represent only habitat or lifestyle markers.
On the one hand, some studies noticed the presence of genes
encoding virulence factors into prophages (i.e., Sitkiewicz et al.,
2006; Tobe et al., 2006). Several prophages have already been
characterized in B. cenocepacia (Table 2; Summer et al., 2004;
Goudie et al., 2008; Lynch et al., 2013b), without the presence
of genes encoding new virulence factors detected (Summer
et al., 2007). However, given the number of prophages not
or only slightly characterized in B. cenocepacia (Table 2),
a direct role of these prophages in the virulence and/or in
particular epidemiological properties of the ET12 strains cannot
be excluded. On the other hand, it can also be suggested
that the substantial presence of prophages in the genome of
ET12 strains is not the cause but the consequence of the
epidemiological success of these strains. Thus, according to
the “kill-the-winner” ecological model, dominant strains in an
ecological niche are more likely to be targeted by phage attacks
(Rodriguez-Valera et al., 2009). The ET12 strains, due to their
epidemiological success, should indeed be at least transiently
dominant in their ecological niche. The substantial presence of
prophages in their genome would result from the numerous
phage attacks that occurred. According to this model, the
environmental strain F01 has probably never been so dominant
in its telluric environment, which would be in accord with
the lowest number of prophages in its genome. Finally, a
third hypothesis could explain this variation in the number
of prophages. A recent ecological model, “the piggyback-the-
winner model,” predicts that phages integrate as prophages and
undergo the lysogenic replication cycle instead of the lytic cycle
when bacterial density and activity increase, especially in internal
mucosal surfaces, such as human lungs (Silveira and Rohwer,
2016).
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The dramatic decline in the effectiveness of antibiotics has
generated renewed interest in phage therapy (Abedon et al.,
2017). The use of bacteriophages as antibacterial therapeutics
is especially important for targeting those pathogens for which
antibiotic treatments are limited, e.g., in B. cenocepacia (Lynch
et al., 2013a; Roszniowski et al., 2017). In this context,
it is interesting to note that the absence of a self-defense
CRISPR system makes these therapeutic approaches even
more promising. Finally, the particular occurrence of prophage
in the epidemiological ET12 strains reinforces the need to
better understand the interactions between B. cenocepacia and
bacteriophages, particularly in a clinical context.
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